“A little background digging revealed to me that this study is the tip of a new iceberg relative to ADHD diagnosis, stimulant treatment, and risk in adulthood of psychotic mental health disorders or episodes,” Lydia Furman, the associate editor of Pediatrics, writes in her review of the recent MacKenzie et al. study. “The public health impact of this seemingly uncommon group of adverse events is magnified by the high population prevalence of children being treated with stimulants for diagnosis of ADHD, reported as 6.1% of all children ages 4-17 years in 2011.”
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.